CI Investments Inc
SRPT icon

CI Investments Inc’s Sarepta Therapeutics SRPT Stock Holding History

CI Investments Inc’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,399
Closed -$24K – 1319
2025
Q2 		$24K Sell
1,399
-837
-37% -$35.7K ﹤0.01% 1147
2025
Q1 		$143K Sell
2,236
-903
-29% -$95.1K ﹤0.01% 808
2024
Q4 		$382K Buy
3,139
+444
+16% +$54.4K ﹤0.01% 569
2024
Q3 		$337K Sell
2,695
-162
-6% -$22.4K ﹤0.01% 551
2024
Q2 		$451K Sell
2,857
-406
-12% -$52.2K ﹤0.01% 493
2024
Q1 		$422K Buy
3,263
+1,081
+50% +$132K ﹤0.01% 504
2023
Q4 		$210K Buy
2,182
+36
+2% +$3.45K ﹤0.01% 633
2023
Q3 		$260K Sell
2,146
-159
-7% -$18K ﹤0.01% 568
2023
Q2 		$264K Buy
2,305
+978
+74% +$126K ﹤0.01% 589
2023
Q1 		$183K Buy
1,327
+605
+84% +$78.5K ﹤0.01% 601
2022
Q4 		$94K Buy
722
+451
+166% +$52.3K ﹤0.01% 769
2022
Q3 		$30K Sell
271
-13
-5% -$1.31K ﹤0.01% 948
2022
Q2 		$21K Buy
284
+70
+33% +$5.15K ﹤0.01% 970
2022
Q1 		$17K Buy
214
+210
+5,250% +$16.1K ﹤0.01% 1062
2021
Q4 		$0 Hold
4
– – ﹤0.01% 1433
2021
Q3 		$0 Buy
+4
New +$308 ﹤0.01% 1385

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CI Investments Inc's SRPT Position: Q3 2025 in Review

CI Investments Inc sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 1,399 shares — an estimated $24K sold.

CI Investments Inc first reported a position in SRPT in Q3 2021 and held it in 16 quarters. The position peaked at $451K in Q2 2024. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • CI Investments Inc reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,399 Sarepta Therapeutics shares in Q3 2025, an estimated $24K.
  • CI Investments Inc first reported a position in Sarepta Therapeutics in Q3 2021 and held it in 16 quarters.
  • CI Investments Inc's Sarepta Therapeutics position peaked at $451K in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on CI Investments Inc's 13F filing for Q3 2025, filed 12 Nov 2025.